比特派官网网站|frontiers in public health

作者: 比特派官网网站
2024-03-08 22:28:27

Frontiers in Public Health

Frontiers in Public Health

Skip to main content

Navigation group Top bar navigation Frontiers in Public Health

About us

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Search Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office

About us

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Submit  your research Search Frontiers in Public Health 5.2 Impact Factor 3.8 CiteScore 102,530 Citations

Submit

Guidelines Submit your research

Start your submission and get more impact for your research by publishing with us.

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors See all (5,139) paolo vineis Imperial College London London, United Kingdom Field Chief Editor

Frontiers in Public Health

colin d butler Australian National University Canberra, Australia Specialty Chief Editor

Planetary Health

cyrille delpierre INSERM Public Health Paris, France Specialty Chief Editor

Life-Course Epidemiology and Social Inequalities in Health

hai fang Peking University Beijing, China Specialty Chief Editor

Health Economics

Articles See all (16,254) Review

Published on 08 Mar 2024

An overview of the ameliorative efficacy of Catharanthus roseus extract against Cd2+ toxicity: implications for human health and remediation strategies

in Environmental health and Exposome Mohammad HashimHussain ArifBaby TabassumShahnawaz RehmanPriya BajajRekha SirohiMohd Faizan Ali Khan Frontiers in Public Health doi 10.3389/fpubh.2024.1327611 Original Research

Published on 08 Mar 2024

Growth in height and its association with overweight and obesity in Mexican children: an evaluation based on a nationally representative sample (ENSANUT 2018)

in Children and Health Luis Alberto FloresSudip Datta BanikNoel CameronIsabel Januário Fragoso Frontiers in Public Health doi 10.3389/fpubh.2024.1339195 Original Research

Published on 08 Mar 2024

Unraveling the link: environmental tobacco smoke exposure and its impact on infertility among American women (18–50 years)

in Environmental health and Exposome Liang PengXiaohan LuoBaodi CaoXiaohui Wang Frontiers in Public Health doi 10.3389/fpubh.2024.1358290 Study Protocol

Published on 08 Mar 2024

Kairos study protocol: a multidisciplinary approach to the study of school timing and its effects on health, well-being and students’ performance

in Public Health Education and Promotion Daniel Gabaldón-EstevanDiego Carmona-TalaveraBelén Catalán-GregoriElena Mañas-GarcíaVanessa Martin-CarbonellLucía MonfortElvira Martinez-BesteiroMònica González-CarrascoMaría Jesús Hernández-JiménezKadri Täht Frontiers in Public Health doi 10.3389/fpubh.2024.1336028 Volumes See all (14)

Volume 12 - 2024

Volume 11 - 2023

Volume 10 - 2022

Volume 9 - 2021

Volume 8 - 2020

Research Topics See all (1,391)

Submission open

AI-Driven Healthcare Delivery, Ageism, and Implications for Older Adults: Emerging Trends and Challenges in Public Health Gul SeckinSusan Hughes, PhD 135

views

Submission open

Novel Interventions for the Prevention and Control of Communicable Disease Roland SalmonGeorge Karani

Submission open

Evaluating Public Health Strategies for Climate Change: Risk and Opportunities Fabio ScarpaAntonello MaruottiMassimo Ciccozzi 209

views

Submission open

Empowering Safe Medication Practices Through Innovative Theory-Based Interventions Yen-Ming HuangChi-Chuan WangTomoya TachiHsun-Yu Chan Learn more about Research Topics Footer Guidelines Author guidelinesEditor guidelinesPolicies and publication ethicsFee policy Explore ArticlesResearch Topics Journals Outreach Frontiers Forum Frontiers Policy Labs Frontiers for Young Minds Connect Help centerEmails and alerts Contact us SubmitCareer opportunities Follow us © 2024 Frontiers Media S.A. All rights reserved Privacy policy | Terms and conditions

Frontiers in Public Health | About

Frontiers in Public Health | About

Skip to main content

Navigation group Top bar navigation Frontiers in Public Health

About us

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Search Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office

About us

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Submit  your research Search Main content

Field chief editor

paolo vineis Imperial College London London, United Kingdom Field Chief Editor

Frontiers in Public Health

Mission & scope Frontiers in Public Health publishes developments in all fields of public health research, aiming to advance our understanding of causal relationships for disease, promote community-based interventions and explore prevention at the community and individual level.

Led by Field Chief Editor Paolo Vineis of Imperial College London, United Kingdom, Frontiers in Public Health welcomes submissions across all areas of the field that advances population health, furthers disease prevention and promotes health for all members of society. Topics include:

• aging and public health

• children and health

• clinical diabetes

• digital public health

• disaster and emergency medicine

• environmental health and exposome

• health economics

• infectious diseases: epidemiology and prevention

• injury prevention and control

• life-course epidemiology and social inequalities in health

• occupational health and safety

• planetary health

• public health education and promotion

• public health policy

• public health and nutrition

• public mental health

• radiation and health

• substance use disorders and behavioral addictions.

The journal welcomes submissions which advance the UN’s Sustainable Development Goals (SDG), notably SDG 3, Good Health and Well-Being, in the effort to address significant global public health concerns, preparedness and develop appropriate mitigation measures.

Manuscripts that focus solely on health services, clinical trials on drugs, medical imaging, and disease-specific studies that do not have a clear public health relevance, are not suitable for publication in this journal. Additionally, studies that are purely predictive or prognostic models without a relevance to public health practice or policy will not be considered. The journal does not accept papers concerning simple bibliometric studies and discourages publication of cross-sectional studies, with exceptions. Authors are welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and have a conclusion related to public health.

Frontiers in Public Health is committed to advancing developments in the field of public health by allowing unrestricted access to articles, welcoming trials on public health interventions, and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.

Ethics Statement for the tobacco industry

In accordance with Frontiers’ Conflict of Interest (COI) policy, for any research article that is sponsored through commercial funding, the role of the funder must be declared to Frontiers in Public Health in full. If that source of funding is tied to the vested interests of the tobacco or e-cigarette industries or affiliated organizations, it will be rejected without passing into peer review.

If undeclared funding information of this type comes to light post-publication, a formal correction or retraction in full will take place. If a researcher is affiliated with, or otherwise incentivized by commercial tobacco or e-cigarette industries or affiliated organizations, the research article will not pass into peer review.

For industries other than tobacco a case-by-case evaluation will be made at Editorial level. There are potential situations of conflict of interest arising e.g. from the food or cosmetics industry or other industries that produce goods that are under scrutiny for safety or that may contribute to ill health.

For more information on Frontiers VALID acceptance criteria see: https://www.frontiersin.org/about/review-system. Frontiers in Public Health is member of the Committee on Publication Ethics.

Facts Short name Front. Public Health Abbreviation fpubh Electronic ISSN 2296-2565 PMCID All published articles receive a PMCID Impact 5.2 Impact Factor 3.8 CiteScore Indexed in

PubMed, MEDLINE, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE), Google Scholar, DOAJ, CrossRef, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, 1Science, CiteFactor, OpenAIRE, Polska Bibliografia Naukowa (PNB), Zetoc, Norwegian Centre for Research Data (NSD), Bielefeld Academic Search Engine (BASE), JuFo

Journal sections

Frontiers in Public Health is composed of the following Specialty

sections:

Aging and Public Health

Children and Health

Digital Public Health

Disaster and Emergency Medicine

Environmental health and Exposome

Health Economics

Infectious Diseases: Epidemiology and Prevention

Injury prevention and control

Life-Course Epidemiology and Social Inequalities in Health

Occupational Health and Safety

Planetary Health

Public Health Education and Promotion

Public Health Policy

Public Health and Nutrition

Public Mental Health

Radiation and Health

Substance Use Disorders and Behavioral Addictions

The specialty sections of

Frontiers in Public Health welcome submission of the following

article types:

Brief Research Report, Case Report, Classification, Clinical Trial, Community Case Study, Conceptual Analysis, Correction, Curriculum, Instruction, and Pedagogy, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy Brief, Policy and Practice Reviews, Review, Study Protocol, Systematic Review, Technology and Code.

When submitting a manuscript to Frontiers in Public Health, authors must

submit the material directly to one of the specialty

sections. Manuscripts are peer-reviewed by the

Associate and Review Editors of the respective specialty section.

Open access statement Frontiers' philosophy is that all research is for the benefit of humankind. Research is the product of an investment by society and therefore its fruits should be returned to all people without borders or discrimination, serving society universally and in a transparent fashion. That is why Frontiers provides online free and open access to all of its research publications. For more information on open access click here. Open access funder and institutional mandatesFrontiers is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Frontiers. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.Copyright statement Under the Frontiers Conditions for Website Use and the Frontiers General Conditions for Authors, authors of articles published in Frontiers journals retain copyright on their articles, except for any third-party images and other materials added by Frontiers, which are subject to copyright of their respective owners. Authors are therefore free to disseminate and re-publish their articles, subject to any requirements of third-party copyright owners and subject to the original publication being fully cited. The ability to copy, download, forward or otherwise distribute any materials is always subject to any copyright notices displayed. Copyright notices must be displayed prominently and may not be obliterated, deleted or hidden, totally or partially.Quality Each Frontiers article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers, who include many of the world's best scientists and scholars. Frontiers is well aware of the potential impact of published research both on future research and on society and, hence, does not support superficial review, light review or no-review publishing models.Frontiers uses the single anonymized peer review model, where the reviewer identity is not made visible to the author, while the author identity is visible to the reviewer, and reviewer and the authors’ identities are visible to the decision-making editor. Reviewers interact with the handling editor and the authors. Editor and reviewer names and affiliations are published on all Frontiers articles.Research must be certified by peers before entering a stream of knowledge that may eventually reach the public - and shape society. Therefore, Frontiers only applies the most rigorous and unbiased reviews, established in the high standards of the Frontiers Review System. Furthermore, only the top certified research, evaluated objectively through quantitative online article level metrics, is disseminated to increasingly wider communities as it gradually climbs the tiers of the Frontiers Tiering System from specialized expert readership towards public understanding.Frontiers has a number of procedures in place to support and ensure the quality of the research articles that are published: 2023

Editorial Board Quality

Only leading experts and established members of the research community are appointed to the Frontiers Editorial Boards. Chief Editors, Associate Editors and Review Editors are all listed with their names and affiliations on the Journal pages and are encouraged to publicly list their publication credentials.

Associate Editor Assignment Quality

Associate Editors oversee the peer-review and take the final acceptance decision on manuscripts. Editorial decision power is distributed in Frontiers, because we believe that many experts within a community should be able to shape the direction of science for the benefit of society.

Submitting authors can choose a preferred Associate Editor to handle their manuscript, because they can judge well who would be an appropriate expert in editing their manuscript. There is no guarantee for this preference of choice, Associate Editors can decline invitations any time, and the handling Associate Editor can also be over-ridden by the Chief Editor before she/he is invited to edit the article or at any other stage.

Associate Editors are mandated to only accept to edit a manuscript if they have no conflicts of interest (as stated here and in their review invitation and assignment emails).

Should it become clear that the Associate Editor has a conflict of interest or is unable to perform the peer-review timely and adequately, a new Associate Editor can be assigned to the manuscript by the Chief Editor, who has full control to intervene in the peer-review process at any time.

The Associate Editor initially checks that the article meets basic quality standards and has no obvious objective errors.

Reviewer Assignment Quality

The Associate Editor can then personally choose and invite the most appropriate reviewers to handle the peer-review of the manuscript, including Review Editors from the board or external reviewers.

The Associate Editor is aided in this by the Frontiers Collaborative Review Forum software and interface, which suggests the most relevant Review Editors based on a match between their expertise and the topic of the manuscript. Associate Editors can however choose any reviewer they deem adequate.

After a certain time frame and if no reviewers have in the meantime been assigned to the manuscript, the Frontiers platform and algorithmic safety-net steps in and invites the most appropriate Review Editors based on constantly updated and improved algorithms that match reviewer expertise with the submitted manuscript.

Review Editors and reviewers are mandated to only accept to review a manuscript if they have no conflicts of interest (as stated here and in their review invitation and assignment emails).

Frontiers algorithms are constantly fine-tuned to better match Review Editors with manuscripts, and additional checks are being coded into the platform, for example regarding conflicts of interest.

Should it become clear that a particular reviewer has a conflict of interest or is unable to perform the peer-review timely and adequately, he or she shall be replaced with an alternative reviewer by the Associate Editor or the Chief Editor, who will be alerted and has full control to intervene into the peer-review at any time.

Independent Review Stage Quality

In the Independent Review Stage the assigned reviewers perform an in-depth review of the article independently of each other to safeguard complete freedom of opinion.

The reviewers are aided by an online standardized review questionnaire – adopted to article types – with the goal to facilitate rigorous evaluation according to objective criteria and the Frontiers Review Guidelines.

Interactive Review Stage Quality

The Associate Editor assesses the reviews and activates the “Interactive Review” – informing the authors of the extent of revisions that are required to address the reviewers’ comments, and starting the Interactive Discussion Forum where authors and also the reviewers get full access to all review reports.

Manuscript and review quality at this stage are enhanced by allowing authors and reviewers to discuss directly with each other in real-time until they reach consensus and a final version of the manuscript is endorsed by the reviewers.

Reviewer identity is protected at this stage to safeguard complete freedom of opinion.

Reviewers can recommend rejection at this stage if their requests to correct objective errors are not being met by the authors or if they deem the article overall of insufficient quality.

Should a dispute arise, authors or reviewers can trigger an arbitration and will alert the Associate Editor, who can assign more reviewers and/or bring the dispute to the attention of the Chief Editor. The Associate Editor can also weigh in on the discussion and is asked to mediate the process to ensure a constructive revision stage.

Decision Stage Quality

The decision to accept an article needs to be unanimous amongst all reviewers and the handling Associate Editor.

The names of the Associate Editor and reviewers are disclosed on published articles to encourage in depth and rigorous reviews, acknowledge work well done on the article and to bring transparency and accountability into peer-review.

Associate Editors can recommend the rejection of an article to the Chief Editor, who needs to check that the authors’ rights have been upheld during the peer-review process, and who can then ultimately reject the article if it is of insufficient quality, has objective errors or if the authors were unreasonably unwilling to address the points raised during the review.

Chief Editors can at any stage of the peer-review step in to comment on the review process, change assigned editors, assign themselves as a reviewer and even as the handling editor for the manuscript, and therefore have full authority and all the mechanisms to act independently in their online editorial office to ensure quality.

Safeguards against Financial Conflicts of Interest

Only leading researchers acting as Associate Editors, who are not part of Frontiers staff, can make acceptance decisions based on reviews performed by external experts acting as Review Editors or reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role to act as Associate or Review Editors, and any award scheme is not linked to acceptances of manuscripts.

Chief Editors receive an honorarium if their specialty section or field reaches certain submission levels. However, this honorarium is based on the total number of submitted articles during a calendar year, and not the number of accepted articles. Therefore they also have no financial incentive to accept manuscripts.

Post-Publication Stage Quality

The Frontiers platform enables post-publication commenting and discussions on papers and hence the possibility to critically evaluate articles even after the peer-review process.

Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct.

Aside Side menu navigation

About this journal

Field chief editor

Mission & scope

Facts

Journal sections

Open access statement

Copyright statement

Quality

Menu Footer Guidelines Author guidelinesEditor guidelinesPolicies and publication ethicsFee policy Explore ArticlesResearch Topics Journals Outreach Frontiers Forum Frontiers Policy Labs Frontiers for Young Minds Connect Help centerEmails and alerts Contact us SubmitCareer opportunities Follow us © 2024 Frontiers Media S.A. All rights reserved Privacy policy | Terms and conditions

Frontiers in Public Health | About

Frontiers in Public Health | About

Skip to main content

Navigation group Top bar navigation Frontiers in Public Health

About us

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Search Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office

About us

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Frontiers in Public Health

Sections

Sections

Aging and Public HealthChildren and HealthDigital Public HealthDisaster and Emergency MedicineEnvironmental health and ExposomeHealth EconomicsInfectious Diseases: Epidemiology and PreventionInjury prevention and controlLife-Course Epidemiology and Social Inequalities in HealthOccupational Health and SafetyPlanetary HealthPublic Health Education and PromotionPublic Health PolicyPublic Health and NutritionPublic Mental HealthRadiation and HealthSubstance Use Disorders and Behavioral Addictions ArticlesResearch TopicsEditorial Board

About journal

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Submit  your research Search Article typesFrontiers offers multiple article types to maximize your options for disseminating your work. Some article types, such as those that mention medicine, are section-specific. Only article types that appear in the drop-down menu during the submission process are available for submission to the selected section.Please refer to your preferred journal and section to clarify which article types are available.Ensure that any manuscript you submit conforms to the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) recommendations for ethics, as well as to the general Frontiers article requirements. All submitted manuscripts will be checked by plagiarism detection software.All Frontiers articles are peer-reviewed, receive a DOI, are citable, published in PDF and HTML format, and submitted for indexing in relevant digital archives.More useful information about submitting:Author guidelinesSubmit your manuscriptFee policy Original Research

Original Research articles report on primary and unpublished studies. Original Research may also encompass confirming studies and disconfirming results which allow hypothesis elimination, reformulation and/or report on the non-reproducibility of previously published results. Original Research articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish an Original Research article. Original Research articles should have the following format: 1) Abstract, 2) Introduction, 3) Materials and Methods, 4) Results, 5) Discussion.

Systematic Review

Systematic Review articles present a synthesis of previous research, and use clearly defined methods to identify, categorize, analyze and report aggregated evidence on a specific topic. Included in this article type are meta-syntheses, meta-analyses, mapping reviews, scoping reviews, systematic reviews, and systematic reviews with a meta-analysis. Systematic Review articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Systematic Review article. Systematic Reviews should: clearly define the research question in terms of population, interventions, comparators, outcomes and study designs (PICOS), and state which reporting guidelines were used in the study. For design and reporting, systematic reviews must conform to the reporting guidelines (e.g., PRISMA, Cochrane, Campbell), and include the PRISMA flow diagram http://prisma-statement.org/prismastatement/flowdiagram.aspx (if applicable), as well as funding information (if no specific funding to carry out the research, please state so). Systematic Reviews should have the following format: 1) Abstract, 2) Introduction, 3) Methods (including study design; participants; interventions; comparators; systematic review protocol; search strategy; data sources; study sections and data extraction; data analysis), 4) Results (including a flow diagram of the studies retrieved for the review; study selection and characteristics; synthesized findings; assessment of risk of bias), 5) Discussion (including summary of main findings; limitations; conclusions). Systematic Reviews must not include unpublished material (unpublished/original data, submitted manuscripts, or personal communications) and may be rejected in review or reclassified, at a significant delay, if found to include such content.

Methods

Methods articles present either a new or established method, protocol, or technique that is of significant interest in the field. Methods articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Methods article. Method articles should have the following format: 1) Abstract, 2) Introduction (outlining the protocol and its possible applications), 3) Materials and Equipment (including a list of reagents/ materials and/or equipment required; formulation of any solutions where applicable), 4) Methods (including objectives and validation of the method; step-by-step procedures; timing of each step or related series of steps; pause points; example(s) of application and effectiveness; details of precision/ accuracy and limits of detection or quantification, where applicable) , 5) (Anticipated) Results (describing and illustrating with figures, where possible, the expected outcome of the protocol; advantages, limitations, possible pitfalls and artifacts and any troubleshooting measures to counteract them), 6) Discussion. Any analytical methods applied to the data generated by the protocol must be referenced or described. Results must be replicable.

Review

Review articles cover topics that have seen significant development or progress in recent years, with comprehensive depth and a balanced perspective. Reviews should present a complete overview of the state of the art (and should not merely summarize the literature), as well as discuss the following: 1) Different schools of thought or controversies, 2) Fundamental concepts, issues, and problems, 3) Current research gaps, 4) Potential developments in the field. Review articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Review article. Review articles should have the following format: 1) Abstract, 2) Introduction, 3) Subsections relevant for the subject, 4) Discussion. Review articles must not include unpublished material (unpublished/original data, submitted manuscripts, or personal communications) and may be rejected in review or reclassified, at a significant delay, if found to include such content.

Mini Review

Mini Review articles cover focused aspects of a current area of investigation and its recent developments. They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field. Mini Reviews articles are peer-reviewed, have a maximum word count of 3,000 and may contain no more than 2 Figures/Tables. Authors are required to pay a fee (B-type article) to publish a Mini Review article. Mini Review articles should have the following format: 1) Abstract, 2) Introduction, 3) Subsections relevant for the subject, 4) Discussion. Mini Review articles must not include unpublished material (unpublished/original data, submitted manuscripts, or personal communications) and may be rejected or reclassified, at a significant delay, if found to include such content.

Policy and Practice Reviews

Policy & Practice Reviews provide a comprehensive coverage and balanced overview of current and relevant topics related to policy, regulations, and guidelines that may be coming from academia, relevant societies, regulatory bodies, industries and others. In contrast to Policy Briefs, this article type provides authors with more space to elaborate on policies and/or guidelines. Policy & Practice Reviews are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Policy & Practice Review. Policy & Practice Reviews should have the following format: 1) Abstract, 2) Introduction, 3) Sections on assessment of policy/guidelines options and implications, 4) Actionable Recommendations, 5) Discussion.

Hypothesis and Theory

Hypothesis and Theory articles present a novel argument, interpretation or model intended to introduce a new hypothesis or theory. They should provide the following: 1) New interpretation of recent data or findings in a specific area of investigation, 2) Accurate presentation of previously posed hypotheses or theories, 3) Hypothesis presented should be testable in the framework of current knowledge, 4) May include original data as well as personal insights and opinions. Hypothesis and Theory articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Hypothesis and Theory article. Hypothesis and Theory articles should have the following format: 1) Abstract, 2) Introduction, 3) Subsections relevant for the subject, 4) Discussion.

Perspective

Perspective articles present a viewpoint on a specific area of investigation. They should provide the following: 1) Discuss current advances and future directions, 2) Clear presentation of the authors’ perspective, 3) Accurate presentation and citations of other authors’ work, 4) May include original data as well as personal insights and opinions. Perspective articles are peer-reviewed, have a maximum word count of 3,000 and may contain no more than 2 Figures/Tables. Authors are required to pay a fee (B-type article) to publish a Perspective article. Perspective articles should have the following format: 1) Abstract, 2) Introduction, 3) Subsections relevant for the subject, 4) Discussion.

Clinical Trial

Clinical Trial articles describe the results of interventional studies related to health. These articles can include pilot studies, safety and efficacy trials, surrogate endpoint studies, and proof-of concept studies. Clinical Trial articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Clinical Trial article. Clinical Trial articles should have the following format: 1) Abstract (please include the clinical trial registry number), 2) Introduction, 3) Materials and Methods (including flow diagram when applicable, for example the CONSORT FLOW DIAGRAM- http://www.consort-statement.org/consort-statement/flow-diagram), 4) Results, 5) Discussion. All clinical trials must be registered in a public trials registry to be considered for publication, and authors should be compliant with the Consolidated Standards of Reporting Trials (CONSORT).

Case Report

Case Reports highlight unique cases of human or animal patients that present with an unexpected/ diagnosis, treatment outcome, or clinical course. Case Reports are peer-reviewed, have a maximum word count of 3,000 and may contain no more than 4 display items (figures, tables, or videos). Authors are required to pay a fee (B-type article) to publish a Case Report article. Authors should follow the CARE guidelines and submit a completed CARE checklist as a supplementary file (template available here: https://www.care-statement.org/checklist).

Case Reports should have the following format: 1) Abstract, 2) Introduction: including what is unique about the case and medical literature references, 3) Case description: including de-identified patient information, relevant physical examination and other clinical findings, relevant past interventions and their outcomes, 4) A figure or table showcasing a timeline with relevant data from the episode of care, 5) Diagnostic assessment, details on the therapeutic intervention, follow-up and outcomes, as specified in the CARE guidelines, 6) Discussion: strengths and limitations of the approach to the case, discussion of the relevant medical literature (similar and contrasting cases), take-away lessons from the case, 7) Patient perspective. Authors are required to obtain written informed consent from the patients (or their legal representatives) for the publication. Only Case Reports that are original and significantly advance the field will be considered. All Case Reports should carry the title “Case Report: ‘area of focus’”. More information on CARE guidelines here: https://www.care-statement.org/

Community Case Study

A community case study documents local experience in delivering a service to meet an identified need, in contrast to investigator-driven research that is typically evidence-based. Herein, community case studies are defined as a description of, and reflection upon, a program or practice geared towards improving the health and functioning of a targeted population. Under this article type, a broad spectrum of manuscripts will be considered that describe novel public health interventions at the behavioural, organizational, community, environmental and/or policy level. Community Case Study articles are peer-reviewed, have a maximum word count of 5,000 and may contain no more than 5 Figures/Tables. Authors are required to pay a fee (B-type article) to publish a Community Case Study article. Community Case Study articles should have the following format: 1) Abstract, 2) Introduction: Description of the nature of the problem being addressed and rationale for the proposed innovation, 3) Context (setting and population) in which the innovation occurs, 4) Detail to understand key programmatic elements, 5) Discussion section that shares practical implications, lessons learned for future applications, 6) Acknowledgment of any conceptual or methodological constraints.

Conceptual Analysis

Conceptual Analysis articles explore the concepts and issues that define a field. They should examine the constituent elements of each concept, and the connections between them. Conceptual Analysis articles must not include unpublished material (unpublished/original data, submitted manuscripts, or personal communications) and may be rejected or reclassified, at a significant delay, if found to include such content. Instead, Conceptual Analysis articles should extend current knowledge by presenting a novel argument, interpretation, model, or critique. Conceptual Analysis articles are peer-reviewed, have a maximum word count of 8,000 words and may contain no more than 10 Figures/Tables. Authors are required to pay a fee (B-type article) to publish a Conceptual Analysis article. Any inclusion of verbatim text must be contained in quotation marks and clearly reference the original source. Conceptual Analysis articles should have the following format: 1) Abstract, 2) Introduction, 3) Subsections relevant for the subject, 4) Discussion.

Classification

Classification articles include a brief commentary and a set of classifications that have previously received scientific scrutiny by expert groups of investigators so as to bring definition and order to nomenclature. As such, Classification Articles will necessarily change from time to time, and be republished, as new information accrues. Classification articles are peer-reviewed, have a maximum word count of 2,000 and may contain no more than 15 Table/Figures. Authors are required to pay a fee (A-type article) to publish a Classification Article. Classification articles should have the following format: 1) Abstract, 2) Introduction (brief commentary) 3) Set of Classifications 4) Discussion.

Curriculum, Instruction, and Pedagogy

Curriculum, Instruction, and Pedagogy (CIP) articles describe innovative curricula, courses, teaching methodologies, teaching formats, educational training programs, pedagogical frameworks such as competency models, evaluation techniques, instructions on data analysis or data collection methods, and other innovative pedagogical elements. CIP articles may also be aimed at graduate students, faculty seeking additional instructional resources, or professional development staff seeking to help practicing teachers into a new procedure. Curriculum, Instruction, and Pedagogy articles are peer-reviewed, have a maximum word count of 5,000 and may contain no more than 5 Figures/Tables. Authors are required to pay a fee (B-type article) to publish a Curriculum, Instruction, and Pedagogy article. Curriculum, Instruction, and Pedagogy articles should have the following format: 1) Abstract, 2) Introduction: Background and rationale for the educational activity innovation, 3) Pedagogical framework(s), pedagogical principles, competencies/standards underlying the educational activity, 4) Learning environment (setting, students, faculty); learning objectives; pedagogical format, 5) Results to date/assessment (processes and tools; data planned or already gathered), 6) Discussion on the practical implications, objectives and lessons learned, 7) Acknowledgment of any conceptual, methodological, environmental, or material constraints. Information should be presented in sufficient detail to enable readers to replicate key elements for their own context.

Data Report

Data Report articles present a description of research datasets. Datasets must be deposited in a public repository and must be fixed and made publicly available upon publication of the report. Data Reports articles are peer-reviewed, have a maximum word count of 3,000 and may contain no more than 2 Figures/Tables. Authors are required to pay a fee (C-type article) to publish a Data Report article. Data Report articles should have the following format: 1) Introduction, 2) Methods used to collect the data, including data collection period, filters applied, and information on how readers may interpret the dataset and reuse the data, 3) Should include some analysis of the data but should not report the results of any single study or group of studies, 4) Relevant subsections, but cannot include Results or Discussion. Data Reports must include the name of the dataset, the database/repository where it has been submitted and the link for confidential peer-review (which should be updated with the public link before publication). Any published Data Report will be considered for retraction should the data be removed from the repository or the access become restricted. Any updates to the dataset(s) should be deposited as independent versions in a repository and the relevant information may be published as Addendum/Commentary linked to the initial Data Report. Any detailed analyses or new scientific insights relating to the Data Report can be submitted as independent research articles. The protocols and methodology used to collect the data can also be submitted as Methods articles.

Policy Brief

Policy Briefs articles are short reports that provide a practical and evidence-based evaluation of policy-related issues. This article type also provides policy options and actionable recommendations which allows it to be used as a decision-making tool. Policy Briefs articles are peer-reviewed, have a maximum word count of 3,000 and may contain no more than 5 Tables/Figures. Authors are required to pay a fee (B-type article) to publish a Policy Brief article. Policy Brief articles should have the following format: 1) Abstract (up to 125 words in a bullet point format), 2) Introduction, 3) Sections on Policy Options and Implications, 4) Actionable Recommendations, 5) Conclusions.

Brief Research Report

Brief Research Report articles present original research and/or preliminary findings in a more succinct way, and with fewer details, than Original Research articles. Additionally, in line with the Frontiers ethos of publishing scientifically-sound discoveries, Brief Research Reports also encourage submission of negative results and may report on the non-reproducibility of previously published results. Brief Research Reports articles are peer-reviewed, have a maximum word count of 4,000 and may contain no more than 4 Figures/Tables. Authors are required to pay a fee (B-type article) to publish a Brief Research Report. Brief Research Report articles should have the following format: 1) Abstract, 2) Introduction, 3) Method, 4) Results, 5) Discussion. Supplementary material may be included with Brief Research Reports.

General Commentary

General Commentary articles provide critical comments on a previous publication at Frontiers. Authors wishing to submit commentaries on articles published outside of Frontiers are encouraged to reformat and submit them as an Opinion type. General Commentary articles are peer-reviewed, have a maximum word count of 1,000 words and may contain no more than 1 Figure/Table. They should not contain unpublished or original data. General Commentary articles must be submitted for consideration to the same Journal and Specialty as the original article. Authors are required to pay a fee (C-type article) to publish a General Commentary article. General Commentary articles should have the following format: 1) Title: “Commentary: Title of the original article” (mandatory), 2) Introduction, 3) Subsections relevant for the subject, 4) Discussion. At the beginning of your General Commentary, please provide the complete citation of the article being commented on.

Opinion

Opinion articles allow authors to contribute viewpoints on the interpretation of recent findings in any research area, value of the methods used, as well as weaknesses and strengths of scientific hypotheses. They should abide to the following guidelines: not contain unpublished or original data, be supported by evidence, be fully referenced, encourage constructive discussion, refrain from emotionally-charged argumentation. Opinion articles are peer-reviewed and have a maximum word count of 2,000 and may contain no more than 1 Figure/Table. Authors are required to pay a fee (C-type article) to publish an Opinion article. Opinion articles should have the following format: 1) Introduction, 2) Subsections relevant for the subject, 3) Discussion.

Correction

Corrigendum/Addendum: should authors notice errors that affect the scholarly record or the integrity of the paper, authors are encouraged to submit a correction online. The correction must detail the reason(s) for the error(s) and include only the elements (e.g. sections, sentence, figure) of the manuscript being revised or corrected. All authors of the original paper need to agree to the request for changes. The contribution to the field statement should be used to clearly state the reason for the Correction. Depending on the extent of the correction required, corrections may require peer review. Authors are informed that requests for changes beyond that described here may not be accepted for publication.

Erratum: should authors notice differences between their approved galley proofs and the final published article, thus leading to errors that affect the scholarly record or the integrity of the paper, authors are encouraged to submit a request for erratum to the Frontiers Production Office (production.office@frontiersin.org), clearly specifying the error and the correct information.

Editorial

Editorials are submitted exclusively by the host editor(s) of a Frontiers Research Topic, to convey to the reader the aims and objectives of the research that pertains to the topic, as well as placing it in a broader context. The Editorial should present the contributing articles of the Research Topic but should not be a mere table of contents. As the final contributing article to the Research Topic, Editorials should be submitted once all expected articles have been accepted and published. Editorials should not include unpublished or original data and the inclusion of references is strongly encouraged. Editorial articles may contain 1 Figure and have a word count of 1,000 for Topics with 5-10 articles. The word limit can be increased for each additional article in the Topic, up to a maximum of 5,000 words for 50 articles or more. Topic editors are not required to pay a fee to publish an Editorial article. Submissions are required to have the title Editorial: "Title of Research Topic".

Technology and Code

Technology & Code articles present new technology, code and/or software or a new application of a known technology or software. This article type aims to open new avenues for theoretical and experimental investigation, data analysis or data reduction within the field of study. Technology & Code articles can also feature studies that implement existing algorithms under novel settings. Technology & Code articles are peer-reviewed, have a maximum word count of 12,000 and may contain no more than 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish Technology & Code article. Technology & Code articles related to innovative software solutions and/or design should be novel, presented in a well-documented, human-readable format and should be placed online in a repository, with an associated DOI/URI for retrieval. To better support the code documentation, authors can also upload a metadata file in different formats (i.e. JSON-LD, Microdata, RDFa) that incorporates all the relevant information. Authors can refer to the schema.org vocabulary, and to the SoftwareApplication/SoftwareSourceCode and Dataset related specifications. Technology & Code articles should have the following format: 1) Abstract, 2) Introduction, 3) Method (including any code description), 4) Results (including examples of use and limitations), 5) Discussion (including scalability and limitations). The following information must also be included: project link (e.g. sourceforge, github), operating system (e.g. Windows, Linux, platform independent), programming language (e.g. Python), any restrictions for non-academic use (e.g. licence needed).

Study Protocol

Study Protocol articles document the design of prospective research and it is intended to facilitate dissemination of ongoing studies and promote transparency. Study Protocol articles are peer-reviewed, have a maximum word count of 12,000 and may include up to 15 Figures/Tables. Authors are required to pay a fee (A-type article) to publish a Study Protocol article. Study Protocol articles should have the following format: 1) Abstract (please include the clinical trial registry number for clinical studies), 2) Introduction, 3) Methods and Analysis (including design; selection/treatment of subjects; interventional methods; data analysis), 4) Discussion, 5) Ethics and Dissemination. For clinical studies, registration in a public clinical trial registry is mandatory prior to the submission of the manuscript and the authors are strongly encouraged to follow the SPIRIT guidelines (http://www.spirit-statement.org/) and checklist. Study Protocols are not considered if other articles relating to the study are already published or in review, if it reports any research data from the study, or for any pilot or feasibility study.

Aside Side menu navigation

For authors

Why submit?

Article types

Author guidelines

Editor guidelines

Publishing fees

Submission checklist

Contact editorial office

Menu Footer Guidelines Author guidelinesEditor guidelinesPolicies and publication ethicsFee policy Explore ArticlesResearch Topics Journals Outreach Frontiers Forum Frontiers Policy Labs Frontiers for Young Minds Connect Help centerEmails and alerts Contact us SubmitCareer opportunities Follow us © 2024 Frontiers Media S.A. All rights reserved Privacy policy | Terms and conditions

发文量2000篇+非预警期刊,2年间影响因子从2分涨至6.461!审稿快 - 知乎

发文量2000篇+非预警期刊,2年间影响因子从2分涨至6.461!审稿快 - 知乎首发于sci、ssci切换模式写文章登录/注册发文量2000篇+非预警期刊,2年间影响因子从2分涨至6.461!审稿快知乎用户fNmF7X今日期刊推荐:Frontiers in Public Health创刊时间:2007出版国家:瑞士ISSN:2296-2565出版商:Frontiers Media S.A.期刊影响因子排名↓↓↓18/182 公共卫生、环境卫生与职业卫生按期刊引文指标 (JCI) 排名↓↓↓49/392 公共卫生、环境卫生与职业卫生Frontiers in Public Health是2018年获得第一个影响因子,这几年的影响因子呈上涨趋势,2021年6.461!增长迅猛!JCR分区中科院分区发文情况Frontiers in Public Health近几年的发文量在呈上涨趋势,2021年文章数为2113篇,发文量大。国人发文占比约为15.6%,位第二。国人近三年投稿最多的组织是四川大学、浙江大学、武汉大学、上海交通大学、北京大学、复旦大学。收稿范围使命与范围:21 世纪的公共卫生:挑战、需求和我们期刊的作用人类对环境的改造进展迅速,但调查其对人类健康影响的研究速度要慢得多。流行病学对于确定对现代公共卫生有重大影响的因果关系至关重要,但是,我们现在意识到,在我们生活的世界中,因果关系变得更加复杂。社会经济地位低下、人口阶层贫困加剧、广泛的环境转变和气候变化的影响都是复杂因果关系的例子,一旦因果关系确定,就必须将相同程度的复杂性应用于公共卫生干预措施得到合理的确立。现在人们承认,个人层面的健康促进效果甚微,而且往往会扩大健康方面的社会经济差异。此外,流行病学研究是事后的并且,特别是在非传染性疾病领域,可能仅在环境中引入潜在危害多年后才会产生结果。因此,需要复杂的基于社区的干预措施来加强因果推论以及准确和详尽的方法来评估和总结证据,从而在研究和公共卫生之间架起一座桥梁。重点是精准预防。随着围绕遗传学、组学和大数据进步的热情浪潮,这已被提议作为公共卫生的新前沿。然而,精准预防可能会产生误导,因为迄今为止大多数预防策略已被证明在社会层面而非易感高危人群中有效。预防主要基于卫生领域以外的干预措施,而系统性而非部门性干预措施可能更有益。该杂志旨在成为一个辩论精确预防的期望和成就的论坛,促进围绕从健康促进到气候变化、交通、环境变化甚至物种多样性的跨部门干预措施的建设性讨论。版面费Frontiers in Public Health自2013年开放获取。OA的费用是按不同类型进行收费:A 类文章$3225:原始研究、系统评价、方法、评价、政策和实践评价、假设和理论、临床试验、分类、技术和规范、研究方案B 类文章$2020:迷你评论、观点、案例报告、社区案例研究、概念分析、课程、教学和教学法、政策简介、简要研究报告C 类文章$490:数据报告、综合评论、观点D 类文章免费:更正、社论。审稿周期通过对近期已发表ORIGINAL RESEARCH审稿速度的抽样统计,大部分文章的审稿周期都是在2个月左右接受,快的有21天可以接受的!慢的也有154天的。整体来说审稿周期属于非常快的。ORIGINALRESEARCH的审稿速度都这么快了,其他类型的文章审稿速度应该更快!仅供参考~~以下为近期官网发表的ORIGINAL RESEARCH实例:1.从收到稿件到接受稿件用时:94天PrEP stigma among current and non-current PrEP users in Thailand: A comparison between hospital and key population-led health service settingsReceived: 15 August 2022; Accepted: 17 November 2022;2. 从收到稿件到接受稿件用时:29天Influenza incidence and air pollution: Findings from a four-year surveillance study of prefecture-level cities in ChinaReceived: 16 October 2022; Accepted: 14 November 2022;3.从收到稿件到接受稿件用时:43天Research on express service defect evaluation based on semantic network diagram and SERVQUAL modelReceived: 29 September 2022; Accepted: 11 November 2022;4. 从收到稿件到接受稿件用时:44天Development of a multi-component tobacco cessation training package utilizing multiple approaches of intervention development for health care providers and patients attending non-communicable disease clinics of Punjab, IndiaReceived: 25 September 2022; Accepted: 08 November 2022;5. 从收到稿件到接受稿件用时:154天Nowcasting unemployment rate during the COVID-19 pandemic using Twitter data: The case of South AfricaReceived: 25 May 2022; Accepted: 26 October 2022;6. 从收到稿件到接受稿件用时:21天Dietary factors and the risk of lung 10cancer by epidermal growth factor receptor mutation status and histological subtypesReceived: 25 October 2022; Accepted: 15 November 2022;7. 从收到稿件到接受稿件用时:53天Associations between air pollution and multimorbidity in the UK Biobank: A cross-sectional studyReceived: 02 September 2022; Accepted: 28 October 2022;8.从收到稿件到接受稿件用时:54天How has the COVID-19 pandemic affected young people?—Mapping knowledge structure and research framework by scientometric analysisReceived: 24 September 2022; Accepted: 17 November 2022;自引率Frontiers in Public Health近几年自引率都很低,2021年的自引率5.2%。完全不用担心自引率的问题。中科院《国际期刊预警名单》2021年12月发布的2021版:不在预警名单中2021年01月发布的2020版:不在预警名单中推荐指数:☆☆☆☆Frontiers in Public Health是医学-公共卫生、环境卫生与职业卫生领域期刊。JCR1区,中科院3区;2021年发文量2113篇,国人发文占15.6%;2021年影响因子为6.461。版面费按不同类型收费,审稿周期大多2个月内左右;自引率低!国人友好!手上有(符合收稿范围)高质量稿件的作者们,赶紧冲冲冲!PS:需要Sci润色、翻译、降重、等服务的老师可以私信小编。发布于 2023-03-03 15:46・IP 属地河北高影响因子科研学术论文​赞同​​添加评论​分享​喜欢​收藏​申请转载​文章被以下专栏收录sci、ssci

如何评价 Frontiers 系列期刊,为何常被称为「水刊」、IF 不保值? - 知乎

如何评价 Frontiers 系列期刊,为何常被称为「水刊」、IF 不保值? - 知乎首页知乎知学堂发现等你来答​切换模式登录/注册科研学术期刊学术期刊SCI期刊如何评价 Frontiers 系列期刊,为何常被称为「水刊」、IF 不保值?关注者256被浏览2,403,215关注问题​写回答​邀请回答​好问题 14​添加评论​分享​52 个回答默认排序Daisy爱焦圈儿医学SCI选刊 合作:Daisy_SCI 备注:知乎​ 关注1. 不能说发在Frontiers上的文章质量都很差,但是我有客户文章质量我自己都看不下去,改都没法改,投了很多1,2分的杂志都被拒掉,评审结果很消极。但是在Frontiers系列5分+杂志投稿,两个审稿人都建议接收。2. 只要你在Frontiers系列杂志社投稿的文章被Frontiers接收过,那么你很有可能会成为这个杂志的审稿人,如果被我第一条的作者审稿,你想象一下,审稿意见是什么水平。3. 我的客户遇到过杂志社编辑直接把审稿意见发给作者列表里的本人审稿。4. 有的稿件,6个审稿人,5个建议拒绝,1个建议修改。一般其他杂志社肯定会直接拒稿。Frontiers一般不会,他会再找审稿人,直到找到另一个建议修改的,发给作者修改。5. 如果被拒稿,修改下重新提交,或者换个Frontiers系列的其他杂志,说明自己按照之前拒稿意见修改了,大概率还是会送外审。这是在你并没有严格按照之前拒稿意见修改的前提下,杂志社编辑对这方面审查及其宽松。综合这几点,品一下,说它分值不保值我觉得一点都不冤。不过最近Frontiers开始有了学术编辑做最终质量评审,出现了按照审稿意见修改后所有审稿人都建议接收但是学术编辑直接拒稿的现象,应该是做了内部审稿质量评估调整,有意在控制不好的风评。毕竟版面费那么贵,发文量那么大,一旦全系被预警,损失巨大。需要推荐杂志的小伙伴,可以点击链接留言~~~急需发表小伙伴,点击链接查看~承蒙大家厚爱,目前这个回答帮到一部分同学,深感荣幸。如有需要推荐杂志的同学,推荐我的付费咨询服务。必须是医学强相关专业,其他专业不擅长不提供咨询。咨询请提供以下内容:1. 文章题目或关键词,如能提供摘要最佳2. 分值/分区/版面费,三个要求我会根据研究内容和要求,提供3个推荐杂志。既往推荐的杂志,有半个月给修改意见,也有无修改直接录用的,但是我不能保证我推荐的一定有反馈,毕竟还跟文章质量有很大关系。我每年投递杂志量以K为单位计算,有一些经验在,只希望可以帮助到你。咨询规则:一篇文章最多10次提问,务必将想说的内容和相关要求整理完整,充分利用好咨询费。编辑于 2022-12-06 14:48​赞同 127​​86 条评论​分享​收藏​喜欢收起​雷克赛德​ 关注frontiers下面的有些期刊,邀请你当guest editor的时候,明确写了让你提交一份名单,他们会邀请名单上的人投稿到你负责的特辑上,你细想想frontiers下的很多期刊最近几年扩张越来越厉害,吃相也越发难看,真的有可能像sr这样被拉黑或者预警当然frontiers sr plos one上也有好文章(虽然比例越来越小),平时找文章一般都是靠scholar搜的,熟悉的学者哪怕发在frontiers上的文章也会读来参考发布于 2022-04-02 21:26​赞同 53​​11 条评论​分享​收藏​喜欢

Frontiers in Public Health-期刊论坛,投稿经验-MedSci.cn

Frontiers in Public Health-期刊论坛,投稿经验-MedSci.cn

资讯

内科

心血管

肿瘤

内分泌

普通内科

消化

呼吸

神经科

传染科

精神心理

肾内科

风湿免疫

血液科

老年医学

外科

头颈外科

胃肠外科

血管外科

肝胆胰外

骨科

普通外科

胸心外科

神经外科

泌尿外科

烧伤科

整形美容

麻醉疼痛

专科科室

罕见病

康复医学

药械

儿科

耳鼻咽喉

口腔科

眼科

政策人文

营养全科

预防公卫

妇产科

中医科

急重症

皮肤性病

影像放射

转化医学

检验病理

护理

热点

临床研究

研究设计

人工智能

智慧医疗

论文基金

医学科普

药物经济

医生集团

职业安全

患者招募

医学科研

公司产业

医学英语

MedSci动态

指南

按科室浏览

肿瘤科

心血管

传染科

妇产科

神经科

儿科

呼吸

内分泌科

血液科

消化

更多科室

工具

临床工具

临床指南

医学计算与公式

ICD-10/ICD-11疾病编码

医迅达

直播

话题

公开课

精品课

科研工具

期刊数据库查询

期刊智能选择

云研究平台

随机化工具

全球基金查询

文献查询

SCI写作宝典

生物医药大词典

其他工具

下载App使用方便更快捷

Medsci 梅斯搜索

公开课

精品课

服务

科研数智化

直播,公开课与精品课

科研加速器

研究者发起的临床研究(IIS)支持

真实世界研究解决方案

药物经济学

医保准入事务

研究方案设计

数据库建立与管理

药物警戒(PV)

真实世界研究执行

数据统计分析

数字化学术传播解决方案

多渠道营销(MCM)

产品医学策略

学术传播(APO)

其它

积分商城

FAQS

1

1

FRONT PUBLIC HEALTH

润色咨询

Frontiers in Public Health

出版年份:暂无数据

年文章数:5420

投稿命中率:

开通期刊会员,数据随心看

出版周期:暂无数据

自引率:暂无数据

审稿周期:

开通期刊会员,数据随心看

前往期刊查询

期刊讨论

|

中国SCI论文

|

期刊主页

|

投稿经验

|

杂志官网

|

投稿链接

|

作者需知

|

PMC链接

|

Pubmed全文检索

GetToolImpactFactorCommentsPageRequest(projectId=1, impactFactorId=13411, id=695b13411, selectType=1, sortType=1, contributeIds=null, level=null, parentIds=[])

期刊论坛

期刊介绍

期刊解读

热门指数

影响指数

投稿信息

期刊对比

期刊阅读

返回查询

期刊讨论

最新讨论(173)

最热讨论

加入社群

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-09-04

膨胀的指挥官

来自安徽省

偏重的研究方向:高血压;公共卫生经验分享:8月26日投完,今天看了下在第三步分配编辑

44

9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-01-02

ms5490197991477510

来自江苏省

审稿速度:6.0 | 投稿命中率:5.0经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。

61

2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-12-04

ms1000001829214282

来自重庆

审稿速度:3.0 | 投稿命中率:25.0偏重的研究方向:心理经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

16

3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-10-30

Sky2809

来自陕西省

审稿速度:2.0 | 投稿命中率:75.0偏重的研究方向:公共卫生经验分享:上线后多久可以检索?开检索证明。

24

1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-12-04

ms8000000585743940

来自上海

审稿速度:6.0 | 投稿命中率:75.0偏重的研究方向:biological age;biomarkers;kidney aging经验分享:Received date: 15 Jul 2023Editorial assignment start date: 21 Jul 2023Independent review start date: 04 Oct 2023Interactive review activated date: 04 Nov 2023Review finalized date: 30 Nov 2023Final validation date: 04 Dec 2023

17

1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-11-24

ms6000001158889404

来自河南省

审稿速度:2.0经验分享:很快

16

0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-07-06

爱爬树的松鼠

审稿速度:24.0 | 投稿命中率:50.0偏重的研究方向:公共卫生经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月

49

0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-06-20

aseasy

来自四川省

送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。

0

0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-06-07

ms7000000669336055

审稿速度:1.0 | 投稿命中率:5.0偏重的研究方向:公共卫生经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么

0

0

[GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向:高血压;公共卫生
经验分享:8月26日投完,今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2108472, encodeId=044a21084e2f3, content=审稿速度:6.0 | 投稿命中率:5.0
经验分享:体验非常不好,邀请的审稿人甚至跟你不是同个学科领域。奇葩的审稿人,让你无条件引用他的全部文章,完了之后直接建议拒稿 。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca002170923, createdName=ms5490197991477510, createdTime=Mon Jan 02 02:11:24 CST 2023, time=2023-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向:心理
经验分享:2023.7.26提交

7.29分配编辑

8.2review

10.22返回两个审稿意见,都是大修

10.25返回修改

10.27审稿人一个同意发表,一个拒绝发表

10.31向编辑申诉和解释,向审稿人再次解释

(期间一个月文章状态停留在互评那一步)

11.26编辑添加审稿人3,审稿人3意见小修

11.27返回修改意见

11.28审稿人3同意发表,编辑当天接收!

真的是一言难尽,有的审稿人就是鸡蛋里挑骨头,有时机会要自己争取,希望我的经历可以帮到大家。ps:我同时还投了另外一篇,另一篇直接秒拒。

, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165802, encodeId=7f232165802dd, content=审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向:公共卫生
经验分享:上线后多久可以检索?开检索证明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/09/079ec78e65a320827653a97c916cec5b.jpg, createdBy=69561776587, createdName=Sky2809, createdTime=Mon Oct 30 21:42:55 CST 2023, time=2023-10-30, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2172926, encodeId=318a21e292624, content=审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向:biological age;biomarkers;kidney aging
经验分享:Received date: 15 Jul 2023
Editorial assignment start date: 21 Jul 2023
Independent review start date: 04 Oct 2023
Interactive review activated date: 04 Nov 2023
Review finalized date: 30 Nov 2023
Final validation date: 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56645561313, createdName=ms8000000585743940, createdTime=Mon Dec 04 21:15:56 CST 2023, time=2023-12-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2170664, encodeId=e63f21e0664dd, content=审稿速度:2.0
经验分享:很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4168992640, createdName=ms6000001158889404, createdTime=Fri Nov 24 09:22:21 CST 2023, time=2023-11-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146702, encodeId=a6782146e02d8, content=审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向:公共卫生
经验分享:送了两个审稿人,审稿人都同意的情况下主编拒稿,投稿长达十个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Thu Jul 06 22:28:29 CST 2023, time=2023-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143955, encodeId=1264214395541, content=送了三个审稿人,期间回来一个评价还可以感觉改改能中,然后杂志在另外两个审稿人没有返回意见的情况下直接拒稿。这骚操作震惊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8bf21656097, createdName=aseasy, createdTime=Tue Jun 20 21:32:13 CST 2023, time=2023-06-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2141315, encodeId=3444214131596, content=审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向:公共卫生
经验分享:第一次投在initial validation被直接拒稿,原因是This manuscript does not fulfill the standards established for the journal to be considered for publication,不知道为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d16570282, createdName=ms7000000669336055, createdTime=Wed Jun 07 20:54:33 CST 2023, time=2023-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2132980, encodeId=3a0d213298030, content=审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向:公共健康
经验分享:第一次投 到第六步了 半个月没动静 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a688269520, createdName=ms8000001850834002, createdTime=Fri May 12 17:48:41 CST 2023, time=2023-05-12, status=1, ipAttribution=广东省)]

2023-05-12

ms8000001850834002

来自广东省

审稿速度:3.0 | 投稿命中率:50.0偏重的研究方向:公共健康经验分享:第一次投 到第六步了 半个月没动静

48

1

展开1条回复

共173条首页上一页下一页尾页页码: 1/18页10条/页

分享您的投稿经验,提升MI经验值,获取更多积分

偏重的研究方向

审稿速度

1个月内

2个月内

3个月内

6个月内

12个月内

24个月内

投稿命中率

非常容易

一般容易

中等

比较困难

非常困难

* 我的经验分享

扫描二维码下载梅斯医学APP,参与讨论!

梅斯医学MedSci-临床医生发展平台

梅斯医学是面向医生的综合互联网平台,应用大数据和人工智能技术链接医生、患者、药械企业等,提供精准数字化医学传播解决方案,优化医疗生态,改善医疗质量,共创美好生活。

关于我们

关于我们

加入我们

版权合作

投资者关系

MedSci Healthcare

友情链接

我们的业务

真实世界研究

科研数智化

数字化学术传播

我们的产品

期刊智能查询

国自然查询分析

临床指南

医学公式计算

医药生物大词典

梅斯精品课

梅斯公开课

新媒体矩阵

梅斯医学

肿瘤新前沿

血液新前沿

风湿新前沿

呼吸新前沿

皮肤新前沿

神经新前沿

消化新前沿

心血管新前沿

生物谷

MedSci App

©Copyright 2012-至今 梅斯(MedSci)

增值电信业务经营许可证

|

备案号 沪ICP备14018916号-1

|

互联网药品信息服务资格证书((沪)-非经营性-2020-0033)

|

出版物经营许可证

上海工商

|

上海网警网络110

|

网络社会征信网

|

违法和不良信息举报中心

|

信息举报中心

|违法举报:021-54481353

|

沪公网安备 31010402000380

本站旨在介绍医药健康研究进展和信息,不作为诊疗方案推荐。如需获得诊断或治疗方面指导,请前往正规医院就诊。

用户应遵守著作权法,尊重著作权人合法权益,不违法上传、存储并分享他人作品。投诉、举报、维权邮箱:editor@medsci.cn,或在此留言

科室

订阅+

更多科室

工具

服务

期刊介绍 | Frontiers 出版社官方中文网站

期刊介绍 | Frontiers 出版社官方中文网站

首页

期刊介绍

出版费用

前沿专刊

联系我们

Frontiers 出版社官方中文网站

Skip to content

首页

期刊介绍

出版费用

前沿专刊

联系我们

期刊介绍

ABCDEFGHIJKLMNOPQRSTUVWXYZ

A

Frontiers in Aging Neuroscience

影响因子:4.362

Frontiers in Agronomy

Frontiers in Applied Mathematics and Statistics

Frontiers in Artificial Intelligence

Frontiers in Astronomy and Space Sciences

B

Frontiers in Behavioral Neuroscience

影响因子:2.512

Frontiers in Big Data

Frontiers in Bioengineering and Biotechnolog

影响因子:3.644

Frontiers in Blockchain

Frontiers in Built Environment

C

Frontiers in Cardiovascular Medicine

影响因子:3.915

Frontiers in Cell and Developmental Biology

影响因子:5.201

Frontiers in Cellular and Infection Microbiology

影响因子:4.123

Frontiers in Cellular Neuroscience

影响因子:3.921

Frontiers in Chemical Engineering

Frontiers in Chemistry

影响因子:3.693

Frontiers in Climate

Frontiers in Communication

Frontiers in Computational Neuroscience

影响因子:2.535

Frontiers in Computer Science

D

Frontiers in Digital Health

Frontiers in Digital Humanities

E

Frontiers in Earth Science

影响因子:2.689

Frontiers in Ecology and Evolution

影响因子:2.416

Frontiers in Education

Frontiers in Endocrinology

影响因子:3.644

Frontiers in Energy Research

影响因子:2.746

Frontiers in Environmental Chemistry

Frontiers in Environmental Science

影响因子:2.749

Frontiers in Evolutionary Neuroscience

F

Frontiers in Forest and Global Change

Frontiers in Future Transportation

G

Frontiers in Genetics

影响因子:3.258

Frontiers in Genome Editing

Frontiers in Global Women’s Health

H

Frontiers in Human Dynamics

Frontiers in Human Neuroscience

影响因子:2.673

I

Frontiers in Immunology

影响因子:5.085

Frontiers in Integrative Neuroscience

影响因子:2.152

M

Frontiers in Marine Science

影响因子:3.661

Frontiers in Materials

影响因子:2.705

Frontiers in Mechanical Engineering

Frontiers in Medical Technology

Frontiers in Medicine

影响因子:3.900

Frontiers in Microbiology

影响因子:4.235

Frontiers in Molecular Biosciences

影响因子:4.188

Frontiers in Molecular Neuroscience

影响因子:4.057

N

Frontiers in Nanotechnology

Frontiers in Neural Circuits

影响因子:3.156

Frontiers in Neuroanatomy

影响因子:3.292

Frontiers in Neuroenergetics

Frontiers in Neuroengineering

Frontiers in Neuroinformatics

影响因子:2.649

Frontiers in Neurology

影响因子:2.889

Frontiers in Neurorobotics

影响因子:2.574

Frontiers in Neuroscience

影响因子:3.707

Frontiers in Nutrition

影响因子:3.365

O

Frontiers in Oncology

影响因子:4.848

Frontiers in Oral Health

P

Frontiers in Pediatrics

影响因子:2.634

Frontiers in Pharmacology

影响因子:4.225

Frontiers in Physics

影响因子:2.638

Frontiers in Physiology

影响因子:3.367

Frontiers in Plant Science

影响因子:4.402

Frontiers in Political Science

Frontiers in Psychiatry

影响因子:2.849

Frontiers in Psychology

影响因子:2.067

Frontiers in Public Health

影响因子:2.483

R

Frontiers in Reproductive Health

Frontiers in Research Metrics and Analytics

Frontiers in Robotics and AI

S

Frontiers in Sociology

Frontiers in Sports and Active Living

Frontiers in Surgery

影响因子:1.826

Frontiers in Sustainability

Frontiers in Sustainable Cities

Frontiers in Sustainable Food System

Frontiers in Synaptic Neuroscience

Frontiers in Systems Neuroscience

影响因子:3.293

T

Frontiers in Toxicology

V

Frontiers in Veterinary Science

影响因子:2.245

Frontiers in Virtual Reality

W

Frontiers in Water

地址:北京市西城区廊房头条 13 号院 E16 栋 WeWork(北京坊)

联系电话:010 – 8620 8060

邮箱:marketing.china@frontiersin.org

手机访问本页

关注我们的微信公众号

一篇优秀的文章,首先是选题|专访Frontiers in Public Health栏目主编 方海教授_腾讯新闻

一篇优秀的文章,首先是选题|专访Frontiers in Public Health栏目主编 方海教授_腾讯新闻

一篇优秀的文章,首先是选题|专访Frontiers in Public Health栏目主编 方海教授

本文来自“Frontiers开放科学平台”,文章仅代表作者观点,与“科研圈”无关。

方海教授,于 2022 年 8 月开始担任 Frontiers in Public Health (IF: 6.461 | Citescore: 4.0) 旗下 Health Economics 栏目主编 (Specialty Chief Editor)。

方海

北京大学中国卫生发展研究中心教授

全球健康发展研究院双聘教授

北京大学中国卫生发展研究中心教授、博士生导师;全球健康发展研究院双聘教授。北京大学医学部-中国疾病预防控制中心疫苗经济学联合研究中心副主任。中国疫苗行业协会疫苗经济学专业委员会主任委员;中国卫生经济学会公共卫生经济专业委员会副主任委员、秘书长。

方海教授加入北京大学之前,曾经先后执教(讲师、助理教授、副教授)于美国加州大学戴维斯分校、迈阿密大学(弗罗里达)、科罗拉多大学丹佛分校。

方海教授主持中国国家社科基金重大项目(首席专家)、国家自然科学基金面上项目和国际合作项目、中国疾病预防控制中心、中华预防医学会、中国医师协会、联合国儿童基金会、比尔及梅琳达盖茨基金会、美国中华医学会、英国医学研究会等资助项目。

方海教授主编《中国疫苗经济学评价指南 2022》,发表中英文学术文章 150 余篇,包括以第一作者或通讯作者在 TheBMJ、JAMA Network Open、The Lancet Regional Health – Western Pacific、BMC Medicine 等国际期刊发表多篇重要文章。

Frontiers in Public Health 是 Frontiers 旗下的开放获取期刊,于 2007 年创办。作为一本跨学科开放获取期刊,Frontiers in Public Health 发表经过严格同行评议的研究,面向全世界的研究人员、学者、临床医生和决策者等发布公共卫生研究论文。该期刊旨在改变目前研究和出版的碎片化现状,追求相关科学主题的一致性,并支持科学发现的传播、转化和实践。

Health Economics 栏目旨在促进健康经济学家、医疗保健专业人员等学术和工业领域的专业讨论。栏目欢迎所有具有跨学科影响力的理论和应用卫生经济学、卫生政策和临床科学的研究。

Frontiers in Public Health是一本公共卫生方面的重要期刊,发表了很多公共卫生方面的优秀论文。卫生经济是 Frontiers in Public Health 中的非常重要的领域,为卫生经济相关研究提供了一个非常好的发表和交流的平台。

——方海 教授

Frontiers:

您如何了解并接触到 Frontiers?是什么契机让您选择加入 Frontiers in Public Health 期刊主编团队,担任 Health Economics 栏目主编?

方海:

Frontiers 是全球第三高被引出版社和第六大出版社,期刊文章阅读和下载次数超过 19 亿次,具有较大的知名度。Frontiers in Public Health 是一本公共卫生方面的重要期刊,发表了很多公共卫生方面的优秀论文。卫生经济是 Frontiers in Public Health 中的非常重要的领域,为卫生经济相关研究提供了一个非常好的发表和交流的平台。

Frontiers:

您对 Frontiers in Public Health 期刊 Health Economics 栏目未来的发展有什么期待和计划?

方海:

希望优秀的论文可以投稿卫生经济栏目,尤其在卫生经济学理论和实证分析这两个方面,有一系列重要的前沿专刊(Research Topic)来引领相关文献的进展,并且希望文章作者来源更加具有代表性,不仅包括高收入国家,也有中低收入国家的作者发表优秀的论文。

Frontiers:

在您看来,什么样的文章才是一篇好的文章?您希望更多地吸引到什么样的学者和文章来投稿?

方海:

一篇优秀的文章,首先是选题,是否对在相关文献中有一定的新发现,新贡献,当然如果可以提出一些新的概念或者方法,就更好了。其次是写作,符合包括必要的内容,并且对之前发表的相关文献要熟悉并且能够指出其存在的不足,本文如何填补或者改进。最后,文章能够对现实有所作用,能够促进经济发展、人类健康,尤其是在公共卫生和卫生经济方面增进人类的知识,推动社会进步。

再次欢迎并感谢方海教授担任栏目主编,期待在他的带领下,Frontiers in Public Health 期刊Health Economics 栏目 将取得长足发展。

关于 Frontiers in Public Health

Frontiers in Public Health 是 Frontiers 旗下的开放获取期刊,于  2007 年创办。

期刊分为以下 18 个栏目:

前沿专刊(Research Topic),是 Frontiers 赋能学术工作者的创新方式之一:前沿专刊由客座主编确定某领域内的研究方向,接收相关领域作者的投稿,最终以文章合辑的形式发表在期刊正刊。

成为客座主编的优势在于:

享受开放获取出版优势,快速提升您的科研成果的影响力;

推动本领域的科研进展,领导更积极的学术讨论;

加强您与本领域科研同行的合作与交流;

丰富学术履历,提升您与合作者的学术影响力。

作为客座主编,在前沿专刊正式建立之前需要完成三个步骤:

确定专刊主题;

邀请2-4位专家(需至少包含一位国际专家)作为共同客座主编组织专刊;

建议潜在的作者名单。

如何成为客座主编?

公众号后台回复“客座主编”,用 1 分钟 填写表单,如您符合要求,Frontiers 相应领域的出版编辑将与您一对一交流。

Frontiers 总部位于瑞士,是全球领先的开放获取(Open Access)出版商,致力于使科学在全球范围内更加开放。欲了解更多详情,欢迎访问 Frontiers 官方网站:www.frontiersin.org.

Frontiers in Public Health | Frontiers 出版社官方中文网站

Frontiers in Public Health | Frontiers 出版社官方中文网站

首页

部分期刊列表

出版费用

前沿专刊

联系我们

English

提交稿件

Frontiers 出版社官方中文网站

跳转到内容

首页

部分期刊列表

出版费用

前沿专刊

联系我们

English

提交稿件

新闻和活动

News & Events

Frontiers in Public Health

2020-09-08

返回

地址:北京市朝阳区三里屯路11号院太古里北区N3楼3层WeWork

联系电话:010 - 8620 8060

邮箱:china@frontiersin.org

京ICP备2021017159号-2

联系我们 ・ 防诈骗提示

手机访问本页

关注我们的微信公众号

Frontiers In Public Health-FRONT PUBLIC HEALTH-学术之家

Frontiers In Public Health-FRONT PUBLIC HEALTH-学术之家

HI,欢迎来到学术之家,发表咨询:400-888-7501  订阅咨询:400-888-7502  股权代码  102064

登录/注册

经营许可

杂志订阅

支付方式

首页

期刊

杂志

SCI

发表

出版社

0

首页

SCI期刊

医学

3区

Frontiers In Public Health

Gold OA文章占比:99.21% OA被引用占比:1 开源占比:0.9893 研究类文章占比:90.32%

Frontiers In Public Health

国际标准简称:FRONT PUBLIC HEALTH

人气 1397

《Frontiers In Public Health》是一本专注于公共卫生、环境卫生与职业卫生领域的English学术期刊,创刊于2007年,由FRONTIERS MEDIA SA出版商出版,出版周期1 issue/year。该刊发文范围涵盖公共卫生、环境卫生与职业卫生等领域,旨在及时、准确、全面地报道国内外公共卫生、环境卫生与职业卫生工作者在该领域的科学研究等工作中取得的经验、科研成果、技术革新、学术动态等。该刊已被SCIE、SSCI、SCI数据库收录,在中科院JCR最新升级版分区表中,该刊分区信息为大类学科医学3区,2022年影响因子为5.2。

3区

中科院分区

Q1

JCR分区

SCIE

/

SSCI

/

SCI

期刊收录

是否预警

ISSN:2296-2565

出版地区:Switzerland

出版周期:1 issue/year

E-ISSN:2296-2565

创刊时间:2007

出版语言:English

是否OA开放访问:开放

研究方向:Medicine-Public Health, Environmental and Occupational Health

影响因子:2.483

年发文量:892

出版商:FRONTIERS MEDIA SA

平均审稿速度:14 Weeks

期刊发表咨询

作者投稿咨询

期刊简介

中科院分区

JCR分区

CiteScore

其它数据

发文统计

投稿提示

Frontiers In Public Health期刊简介

Frontiers in Public Health is a multidisciplinary open-access journal which publishes rigorously peer-reviewed research and is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians, policy makers and the public worldwide. The journal aims at overcoming current fragmentation in research and publication, promoting consistency in pursuing relevant scientific themes, and supporting finding dissemination and translation into practice.

Frontiers in Public Health is organized into Specialty Sections that cover different areas of research in the field. Please refer to the author guidelines for details on article types and the submission process.

Frontiers In Public Health中科院分区

中科院分区2022年12月升级版

大类学科

分区

小类学科

分区

Top期刊

综述期刊

医学

3区

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

公共卫生、环境卫生与职业卫生

3区

中科院分区2021年12月基础版

大类学科

分区

小类学科

分区

Top期刊

综述期刊

医学

3区

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

公共卫生、环境卫生与职业卫生

3区

中科院分区2021年12月升级版

大类学科

分区

小类学科

分区

Top期刊

综述期刊

医学

3区

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

公共卫生、环境卫生与职业卫生

3区

中科院分区2020年12月旧的升级版

大类学科

分区

小类学科

分区

Top期刊

综述期刊

医学

4区

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

公共卫生、环境卫生与职业卫生

3区

中科院分区:中科院分区是SCI期刊分区的一种,是由中国科学院国家科学图书馆制定出来的分区。主要有两个版本,即基础版和升级版。基础版是《2019年中国科学院文献情报中心期刊分区表》;升级版是对基础版的延续和改进,将期刊由基础版的13个学科扩展至18个,科研评价将更加明确。

JCR分区

JCR 分区等级

JCR 学科

分区

Q1

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q1

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q1

JCR分区:JCR(Journal Citation Reports)由科睿唯安公司(前身为汤森路透)开发。JCR没有设置大类,只将期刊分为176个具体学科,也就是中科院分区中的小类学科。基于不同学科的当年影响因子高低进行排序,将期刊的数量均匀分为四个部分,Q1区代表学科分类中影响因子排名前25%的期刊,以此类推,Q2区为前25%-50%期刊,Q3区为前50%-75%期刊,Q4区为75%以后期刊。

CiteScore 指数

SJR:1.125

SNIP:1.374

CiteScore排名:

学科类别

分区

排名

百分位

大类:Medicine

小类:Public Health, Environmental and Occupational Health

Q2

220 / 577

61%

CiteScore值计算方式:CiteScore 2021 计算在 2018-2021 年间对 2018-2021 年所发表文章、评论、会议论文、书籍章节和数据论文进行的引用次数,然后将该次数除以在 2018-2021 年所发表的出版物总数。

CiteScore数据来源:是由全球著名学术出版商Elsevier(爱思唯尔)基于其Scopus数据库推出的期刊评价指标。CiteScore指数以四年区间为基准来计算每本期刊的平均被引用次数,并提供期刊领域排名、期刊分区的相关信息,它的作用是测量期刊的篇均影响力。

其它数据分析对比

近年中科院JCR分区趋势图

近年IF值(影响因子)趋势图

影响因子:是美国科学信息研究所(ISI)的期刊引证报告(JCR)中的一项数据。指的是某一期刊的文章在特定年份或时期被引用的频率,是衡量学术期刊影响力的一个重要指标。自1975年以来,每年定期发布于“期刊引证报告”(JCR)。

发文统计(统计区间:2019年-2021年)

机构名称

发文量

UNIVERSITY OF LONDON

58

UNIVERSITY OF CALIFORNIA SYSTEM

56

HARVARD UNIVERSITY

38

UNIVERSITY OF TEXAS SYSTEM

38

UNIVERSITY OF NORTH CAROLINA

28

STATE UNIVERSITY SYSTEM OF FLORI...

27

MONASH UNIVERSITY

26

UNIVERSITY OF SYDNEY

24

JOHNS HOPKINS UNIVERSITY

23

MAASTRICHT UNIVERSITY

23

国家/地区

发文量

USA

558

CHINA MAINLAND

226

England

163

Australia

162

Italy

112

Canada

94

GERMANY (FED REP GER)

91

India

78

France

68

Netherlands

64

文章引用名称

引用次数

Best Practices for Developing an...

153

RE-AIM Planning and Evaluation F...

83

Chagas Disease: From Discovery t...

54

Enhancing the Impact of Implemen...

42

The Old and the New Antibiotics ...

37

From classification to causality...

35

Ignoring Adjuvant Toxicity Falsi...

31

Synthetic and Non-synthetic Cann...

28

RE-AIM in Clinical, Community, a...

26

Personality Associations With Sm...

25

被引用期刊名称

数量

FRONT PUBLIC HEALTH

155

INT J ENV RES PUB HE

117

PLOS ONE

74

BMC PUBLIC HEALTH

42

SCI REP-UK

42

BMJ OPEN

39

IMPLEMENT SCI

27

NUTRIENTS

24

FRONT PSYCHIATRY

22

JMIR MHEALTH UHEALTH

22

引用期刊名称

数量

PLOS ONE

333

LANCET

250

FRONT PUBLIC HEALTH

155

AM J PUBLIC HEALTH

133

BMC PUBLIC HEALTH

131

J CLIN MICROBIOL

125

IMPLEMENT SCI

124

NEW ENGL J MED

115

EMERG INFECT DIS

102

BMJ-BRIT MED J

101

投稿注意事项

文章要求:

1、建议稿件控制10页以上,文章撰写语言为英语;(单栏格式,单倍行距,内容10号字体,文稿类型包含:原创研究(Original Research)、案例报告(Case Report)、文献综述(Literature Review)等;文件格式包含word、PDF、LaTeX等。

2、稿件重复率控制10%以内,论文务必保证原创性、图标、公式、引文等要素齐备,保证附属资料的完整。已发表或引用过度的文章将不会被出版和检索,禁止一稿多投,拒绝抄袭、机械性的稿件。

3、稿件必须有较好的英语表达水平,有图,有表,有公式,有数据或设计,有算法(方案,模型),实验,仿真等;参考文献控制25条以上,参考文献引用一半以上控制在近5年以内。

图片和图表要求:

1、建议使用TIFF、EPS、JPEG格式 ,TIFF格式 使用LZW压缩。

2、文件大小最大不超过20MB,不要以单个文件的形式上传数据。

3、彩色图片的分辨率≥300dpi;黑白图片的分辨率在≥500dpi;line art图片类型的分辨率≥1000dpi;色彩模式建议采用RGB,除非期刊注明要CMYK。

4、线条不要细于0.25pt,也不能太粗,超过1.5pt,过细或过粗都影响美观。

5、表格一般和manuscrript放置在一个word文档里部分期刊 需要单独上传表格。

作者信息:

1、包括作者姓名、最高学位,作者单位(精确到部门),邮箱,地址,邮编,关键词,内容,总结,项目基金,参考文献,作者相片+简介(一定要确保作者信息准确无误,提交稿件之后这部分不能再作改动)。

更多征稿细则请查阅杂志社征稿要求。本站专注期刊投稿服务十年,确保SCI检索,稿件信息安全保密,合乎学术规范不成功不收费,详情请咨询客服。

杂志社联系方式

AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015

上一本:Journal Of Land Use Science

下一本:Frontiers In Veterinary Science

同类期刊

Epidemiology And Health

中科院分区  3区

Tobacco Regulatory Science

中科院分区  4区

Current Environmental Health Reports

中科院分区  2区

Jmir Public Health And Surveillance

中科院分区  3区

Mmwr Recommendations And Reports

中科院分区  1区

Mmwr Surveillance Summaries

中科院分区  1区

Archives Of Public Health

中科院分区  4区

Journal Of Epidemiology And Global Health

中科院分区  4区

国内期刊

Journal of Harbin Institute of Technology

Journal of Beijing Institute of Technology

Journal of Wuhan University of Technology

Journal of Rare Earths

Journal of Earth Science

Journal of Mountain Science

Journal of Bionic Engineering

Chinese Journal of Polymer Science

Journal of Semiconductors

Journal of Thermal Science